Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 77

1.

Suppressive and Gut Reparative Functions of Human Type 1 T-regulatory Cells.

Cook L, Stahl M, Han X, Nazli A, MacDonald KN, Wong MQ, Tsai K, Dizzell S, Jacobson K, Bressler B, Kaushic C, Vallance BA, Steiner TS, Levings MK.

Gastroenterology. 2019 Sep 9. pii: S0016-5085(19)41310-3. doi: 10.1053/j.gastro.2019.09.002. [Epub ahead of print]

PMID:
31513797
2.

Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease.

Turpin W, Espin-Garcia O, Bedrani L, Madsen K, Meddings JB, Raygoza Garay JA, Silverberg MS, Smith MI, Griffiths AM, Moayyedi P, Marshall JK, Mack D, Seidman EG, Ropeleski M, Feagan BG, Jacobson K, Turner D, Walters T, Paterson AD; CCC GEM Project Research Consortium , Xu W, Croitoru K.

Inflamm Bowel Dis. 2019 Oct 18;25(11):1796-1804. doi: 10.1093/ibd/izz116.

PMID:
31251335
3.

Body mass index and risk of inflammatory bowel disease: A systematic review and dose-response meta-analysis of cohort studies of over a million participants.

Rahmani J, Kord-Varkaneh H, Hekmatdoost A, Thompson J, Clark C, Salehisahlabadi A, Day AS, Jacobson K.

Obes Rev. 2019 Sep;20(9):1312-1320. doi: 10.1111/obr.12875. Epub 2019 Jun 12. Review.

PMID:
31190427
4.

Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn's disease patients.

Foster AJ, Smyth M, Lakhani A, Jung B, Brant RF, Jacobson K.

World J Gastroenterol. 2019 Mar 14;25(10):1266-1277. doi: 10.3748/wjg.v25.i10.1266.

5.

Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data.

Coward S, Clement F, Benchimol EI, Bernstein CN, Avina-Zubieta JA, Bitton A, Carroll MW, Hazlewood G, Jacobson K, Jelinski S, Deardon R, Jones JL, Kuenzig ME, Leddin D, McBrien KA, Murthy SK, Nguyen GC, Otley AR, Panaccione R, Rezaie A, Rosenfeld G, Peña-Sánchez JN, Singh H, Targownik LE, Kaplan GG.

Gastroenterology. 2019 Apr;156(5):1345-1353.e4. doi: 10.1053/j.gastro.2019.01.002. Epub 2019 Jan 10.

6.

Management of Paediatric Patients With Medically Refractory Crohn's Disease Using Ustekinumab: A Multi-Centred Cohort Study.

Chavannes M, Martinez-Vinson C, Hart L, Kaniki N, Chao CY, Lawrence S, Jacobson K, Hugot JP, Viala J, Deslandres C, Jantchou P, Seidman EG.

J Crohns Colitis. 2019 Apr 26;13(5):578-584. doi: 10.1093/ecco-jcc/jjy206.

PMID:
30541021
7.

Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study.

Benchimol EI, Kuenzig ME, Bernstein CN, Nguyen GC, Guttmann A, Jones JL, Potter BK, Targownik LE, Catley CA, Nugent ZJ, Tanyingoh D, Mojaverian N, Underwood FE, Siddiq S, Otley AR, Bitton A, Carroll MW, deBruyn JC, Dummer TJ, El-Matary W, Griffiths AM, Jacobson K, Leddin D, Lix LM, Mack DR, Murthy SK, Peña-Sánchez JN, Singh H, Kaplan GG; Canadian Gastro-Intestinal Epidemiology Consortium.

Clin Epidemiol. 2018 Nov 8;10:1613-1626. doi: 10.2147/CLEP.S178056. eCollection 2018.

8.

Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn's disease.

Carman N, Tomalty D, Church PC, Mack DR, Benchimol EI, Otley AR, Jacobson K, Huynh HQ, DeBruyn JC, El-Matary W, Sherlock M, Van Limbergen J, Griffiths AM, Walters TD; Canadian Children Inflammatory Bowel Disease Network: A Joint Partnership of Canadian Institutes of Health Research and the Children with Intestinal and Liver Disorders Foundation.

Gastrointest Endosc. 2019 Feb;89(2):364-372. doi: 10.1016/j.gie.2018.09.025. Epub 2018 Sep 28.

PMID:
30273592
9.

Higher Postinduction Infliximab Serum Trough Levels Are Associated With Healing of Fistulizing Perianal Crohn's Disease in Children.

El-Matary W, Walters TD, Huynh HQ, deBruyn J, Mack DR, Jacobson K, Sherlock ME, Church P, Wine E, Carroll MW, Benchimol EI, Lawrence S, Griffiths AM.

Inflamm Bowel Dis. 2019 Jan 1;25(1):150-155. doi: 10.1093/ibd/izy217.

PMID:
29912413
10.

The Muc2 mucin coats murine Paneth cell granules and facilitates their content release and dispersion.

Stahl M, Tremblay S, Montero M, Vogl W, Xia L, Jacobson K, Menendez A, Vallance BA.

Am J Physiol Gastrointest Liver Physiol. 2018 Aug 1;315(2):G195-G205. doi: 10.1152/ajpgi.00264.2017. Epub 2018 Apr 26.

11.

Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome.

Celiberto LS, Graef FA, Healey GR, Bosman ES, Jacobson K, Sly LM, Vallance BA.

Immunology. 2018 Sep;155(1):36-52. doi: 10.1111/imm.12939. Epub 2018 May 16. Review.

12.

Frontline defenders: goblet cell mediators dictate host-microbe interactions in the intestinal tract during health and disease.

Allaire JM, Morampudi V, Crowley SM, Stahl M, Yu H, Bhullar K, Knodler LA, Bressler B, Jacobson K, Vallance BA.

Am J Physiol Gastrointest Liver Physiol. 2018 Mar 1;314(3):G360-G377. doi: 10.1152/ajpgi.00181.2017. Epub 2017 Nov 9. Review.

13.

Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.

Benchimol EI, Kaplan GG, Otley AR, Nguyen GC, Underwood FE, Guttmann A, Jones JL, Potter BK, Catley CA, Nugent ZJ, Cui Y, Tanyingoh D, Mojaverian N, Bitton A, Carroll MW, deBruyn J, Dummer TJB, El-Matary W, Griffiths AM, Jacobson K, Kuenzig ME, Leddin D, Lix LM, Mack DR, Murthy SK, Sánchez JNP, Singh H, Targownik LE, Vutcovici M, Bernstein CN.

Am J Gastroenterol. 2017 Sep;112(9):1485. doi: 10.1038/ajg.2017.271. Epub 2017 Aug 22.

14.

Transition clinic attendance is associated with improved beliefs and attitudes toward medicine in patients with inflammatory bowel disease.

Fu N, Jacobson K, Round A, Evans K, Qian H, Bressler B.

World J Gastroenterol. 2017 Aug 7;23(29):5405-5411. doi: 10.3748/wjg.v23.i29.5405.

15.

Concomitant Therapy with Immunomodulator Enhances Infliximab Durability in Pediatric Inflammatory Bowel Disease.

Cheng J, Hamilton Z, Smyth M, Barker C, Israel D, Jacobson K.

Inflamm Bowel Dis. 2017 Oct;23(10):1762-1773. doi: 10.1097/MIB.0000000000001212.

PMID:
28837517
16.

Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review.

Lawrence SJ, Sadarangani M, Jacobson K.

Front Pediatr. 2017 Jul 24;5:161. doi: 10.3389/fped.2017.00161. eCollection 2017.

17.

Repression of Salmonella Host Cell Invasion by Aromatic Small Molecules from the Human Fecal Metabolome.

Peixoto RJM, Alves ES, Wang M, Ferreira RBR, Granato A, Han J, Gill H, Jacobson K, Lobo LA, Domingues RMCP, Borchers CH, Davies JE, Finlay BB, Antunes LCM.

Appl Environ Microbiol. 2017 Sep 15;83(19). pii: e01148-17. doi: 10.1128/AEM.01148-17. Print 2017 Oct 1.

18.

Rural and Urban Residence During Early Life is Associated with Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study

Benchimol EI, Kaplan GG, Otley AR, Nguyen GC, Underwood FE, Guttmann A, Jones JL, Potter BK, Catley CA, Nugent ZJ, Cui Y, Tanyingoh D, Mojaverian N, Bitton A, Carroll MW, deBruyn J, Dummer TJB, El-Matary W, Griffiths AM, Jacobson K, Kuenzig ME, Leddin D, Lix LM, Mack DR, Murthy SK, Sánchez JNP, Singh H, Targownik LE, Vutcovici M, Bernstein CN.

Am J Gastroenterol. 2017 Sep;112(9):1412-1422. doi: 10.1038/ajg.2017.208. Epub 2017 Jul 25. Erratum in: Am J Gastroenterol. 2017 Sep;112(9):1485.

19.

Long-term Outcomes of Infliximab Use for Pediatric Crohn Disease: A Canadian Multicenter Clinical Practice Experience.

deBruyn JC, Jacobson K, El-Matary W, Carroll M, Wine E, Wrobel I, Van Woudenberg M, Huynh HQ.

J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):268-273. doi: 10.1097/MPG.0000000000001672.

PMID:
28657923
20.

Allied Health Professional Support in Pediatric Inflammatory Bowel Disease: A Survey from the Canadian Children Inflammatory Bowel Disease Network-A Joint Partnership of CIHR and the CH.I.L.D. Foundation.

El-Matary W, Benchimol EI, Mack D, Huynh HQ, Critch J, Otley A, Deslandres C, Jacobson K, deBruyn J, Carroll MW, Wine E, Van Limbergen J, Sherlock M, Bax K, Lawrence S, Seidman E, Issenman R, Walters TD, Church P, Griffiths AM.

Can J Gastroenterol Hepatol. 2017;2017:3676474. doi: 10.1155/2017/3676474. Epub 2017 May 16.

Supplemental Content

Loading ...
Support Center